Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
This study is currently recruiting participants.
Verified August 2012 by Tracon Pharmaceuticals Inc.
Sponsor:
Tracon Pharmaceuticals Inc.
Collaborators:
Roswell Park Cancer Institute
Information provided by (Responsible Party):
Tracon Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT01326481
First received: March 25, 2011
Last updated: December 10, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |